1) premixed insulin
预混胰岛素
1.
Objectives:To compare the once-daily basal insulin(insulin glargine) plus 1 or 2 OAD versus twice-daily premixed insulin(70/30) plus 1 or 2 OAD as therapy for Type 2 diabetes mellitus on efficacy and safety of clinical study.
目的:对一天一次基础胰岛素(甘精胰岛素)联合1或2种OAD (Oral Anti-diabetic Drug,OAD)与一天两次预混胰岛素(70/30)联合1或2种OAD在治疗2型糖尿病(Type 2 diabetes mellitus,T2DM)的疗效与安全性方面进行临床比较。
2.
Methods:Sixty cases which were in accordance with the inclusion criteria of type 2 diabetes of preliminary diagnosis were randomly divided into group A(insulin glargine and metformin tablets or acarbose) and group B(premixed insulin).
方法:将符合纳入标准的60例初诊2型糖尿病患者随机分为A组(甘精胰岛素联合口服二甲双胍片或阿卡波糖片组)30例,B组(预混胰岛素组)30例。
2) insulin preconditioning
胰岛素预处理
1.
Delayed protection of insulin preconditioning during myocardic ischemia-reperfusion injury in rats;
胰岛素预处理对心肌缺血性损伤的延迟相保护
3) Insulin's mixed liquid
胰岛素混合液
4) insulin zinc suspension
胰岛素锌混悬液
5) insulin aspart 30/70
预混门冬氨酸胰岛素30/70
1.
Objective To investigate the efficacy and safety of insulin aspart 30/70 in the treatment of type 2 diabetes mellitus(T2DM).
目的观察预混门冬氨酸胰岛素30/70(降血糖药)对2型糖尿病的疗效与安全性。
6) Semilente Insulin Zinc Suspension
半慢胰岛素锌混悬液
补充资料：预混胰岛素
预混胰岛素：为了适应进一步的需要，进口胰岛素又将其中的短效制剂和中效制剂（r和n）进行不同比例的混合，产生作用时间介于两者之间的预混胰岛素。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条